Alexza Pharmaceuticals Inc. Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31)
Alexza Pharmaceuticals Inc. had Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) of $2.60 million as of 2016-03-31, per its 10-Q filed 2016-05-13.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:LiabilitiesFairValueDisclosureRecurring · last filed 2016-05-13
- 2016-03-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $2.60M.
- 2015-12-31: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $2.80M.
- 2015-09-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $11.70M.
- 2015-06-30: Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) $15.90M.
| Period end | Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) |
|---|---|
| 2016-03-31 | $2.60M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $2.80M 10-Q · filed 2016-05-13 |
| 2015-09-30 | $11.70M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $15.90M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $15.10M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $30.80M 10-K · filed 2016-03-28 |
| 2014-09-30 | $33.60M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $32.50M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $40.10M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $39.20M 10-K · filed 2015-03-13 |
| 2013-09-30 | $43.30M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $42.00M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $20.50M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $9.60M 10-Q · filed 2013-11-06 |
| 2012-09-30 | $10.50M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $10.50M 10-Q · filed 2012-08-08 |
| 2011-12-31 | $16.50M 10-K · filed 2013-03-26 |